Zoetis
| Company type | Public | 
|---|---|
| Industry | Pharmaceutical | 
| Founded | 1952 | 
| Headquarters | Parsippany, New Jersey, U.S. | 
| Area served | Worldwide | 
| Key people | 
 | 
| Revenue | US$9.26 billion (2024) | 
| US$3.39 billion (2024) | |
| US$2.49 billion (2024) | |
| Total assets | US$14.2 billion (2024) | 
| Total equity | US$4.77 billion (2024) | 
| Number of employees | 13,800 (2024) | 
| Website | zoetis | 
| Footnotes / references | |
Zoetis Inc. (/zō-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index.